FOLFIRI-bevacizumab regimen

View Patient Information

A regimen consisting of bevacizumab, fluorouracil, irinotecan and leucovorin that may be used in the treatment of appendiceal adenocarcinoma, colorectal cancer, and small bowel adenocarcinoma.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	FOLFIRI-Avastin regimen FOLFIRI/bevacizumab regimen folinic acid-fluorouracil-irinotecan-bevacizumab regimen

FOLFIRI-bevacizumab regimen

Search NCI's Drug Dictionary